Clinical Trial Update: Evaluation of the Bimatoprost Implant System Used in Combination With the SpyGlass Intraocular Lens Compared to Timolol Ophthalmic Solution [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/2 clinical trial evaluates the Bimatoprost Implant System used with a SpyGlass intraocular lens, comparing it to Timolol ophthalmic solution …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Bimatoprost Implant System (bimatoprost)
• Timolol ophthalmic solution (timolol)

Snippet

Sponsor: SpyGlass Pharma, Inc. | Conditions: Cataract, Glaucoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING